您好，欢迎来到国际肝病网！
其他专题：
APASL
|
APASL2014
|
APASL2013
|
APASL2012
|
APASL2011
|
APASL2010
|
APASL2009
|
国际肝病
网站首页
专题首页
会议动态
摘要赏析
专家访谈
现场快报
主题演讲
壁报展示
精彩幻灯
图片新闻
视频播报
精彩幻灯
专题首页
» 精彩幻灯
[APASL2011]Emerging Trends in the Management of Hepatitis B: New Predictors and Perspectives
[APASL2011]Enlightening the future: The coming era of individualized treatment of chronic hepatitis B
[APASL2011]From chronic hepatitis to fibrosis and cirrhosis——what do pathologists view through the microscope?
[APASL2011]Future Perspective of Liver Transplantation in Asia
[APASL2011]HBV Genotypes Distribution Worldwide
[APASL2011]Nutritional Issues in patients with Liver Disease Undergoing Resection
[APASL2011]Direct-acting Antiviral Agents for Chronic Hepatitis C and Viral Resistance — The Expected Problem of the Future
[APASL2011]Hepatopulmonary syndrome and portopulmonary hypertension: Modern concept of
[APASL2011]Practical issues to increase compliance and SVR in HCV
[APASL2011]《J Gastroenterology and Hepatology》:Hot topics in Asia-Pacific hepatology
[APASL2011]Highlights from hepatology
[APASL2011]Treatment of early Hepatocellular Carcinoma:Towards personalized therapy
[APASL2011]Imaging of Difficult Nodules in Cirrhosis
[APASL2011]Drug resistant HBV management-oral nucleoside/nucleotide analogues modification is better than
[APASL2011]Emerging Trends in the Management of Cholestatic Liver Diseases
[APASL2011]Emerging Trends in the Management of Chronic HCV
[APASL2011]Role of HBsAg titer in the treatment of chronic hepatitis B
[APASL2011]Emerging Trends in the Management of NASH
[APASL2011]Emerging Trends in the Management of HCC
[APASL2011]Predictive Value of HBsAg in NA and Immune Modulation in HBV
首页
1
2
3
下一页
尾页
专题标签
学术领域
扫描二维码，用手机看今日话题
